Resveratrol affects the cross talk between immune and colon cancer cells

Biomedicine and Pharmacotherapy

Volumn 67, Issue 1, 2013, Pages 43-47

  Bergman, Michael ^a,b   Levin, Gal Sahav ^a,b   Bessler, Hanna ^a,b   Djaldetti, Meir ^a,b   Salman, Hertzel ^a,b  

^a HASHARON HOSPITAL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Colon cancer cells; Cytokines; Mononuclear cells; Resveratrol

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; RESVERATROL; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER CELL; CELL PROLIFERATION; CELL STRAIN HT29; COLON CARCINOGENESIS; COLON CARCINOMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN SECRETION;

ADULT; CELL LINE, TUMOR; COLONIC NEOPLASMS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HT29 CELLS; HUMANS; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; STILBENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84873095956     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2012.10.008     Document Type: Article

References (27)

1. Yadav M., Jain S., Bhardwaj A., Nagpal R., Puniya M., Tomar R., et al. Biological and medicinal properties of grapes and their bioactive constituents: an update. J Med Food 2009, 12:473-484.
2. Kaur G., Roberti M., Raul F., Pendurthi U.R. Suppression of human monocyte tissue factor induction by red wine phenolic and synthetic derivatives of resveratrol. Thromb Res 2007, 119:247-256.
3. Penumathsa S.V., Thirunavukkarasu M., Koneru S., Juihasz B., Zhan L., Pant R., et al. Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat. J Mol Cell Cardiol 2007, 42:508-516.
4. Penumathsa S.V., Maulik N. Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease. Can J Physiol Pharmacol 2009, 87:275-286.
5. Szabo G. A glass of red wine to improve mitochondrial biogenesis? Novel mechanisms of resveratrol. Am J Physiol Heart Circ Physiol 2009, 297:H8-H9.
6. Csiszar A., Labinskyy N., Pinto J.T., Ballabh P., Zhang H., Losonczy G., et al. Resveratrol induces mitochondrial biogenesis in endothelial cells. Am J Physiol Heart Circ Physiol 2009, 297:H13-H20.
7. Marques F.Z., Markus M.A., Morris B.J. Resveratrol: Cellular actions of a potent natural chemical that confers a diversity of health benefits. Int J Biochem Cell Biol 2009, 41:2125-2128.
8. Harikumar K.B., Aggarwal B.B. Resveratrol. A multitargeted agent for age-associated chronic diseases. Cell Cycle 2008, 7:1020-1035.
9. Grivennikov S.I., Karin M. Inflammatory cytokines and cancer: tumor necrosis factor and interleukin 6 take the stage. Ann Rheum Dis 2011, 70(Suppl 1):104-108.
10. de la Lastra C.A., Villegas I. Resveratrol is an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol Nutr Food Res 2005, 49:405-430.
11. Poolman T.M., Ng L.L., Manson M.M. Inhibition of the respiratory burst by resveratrol in human monocytes: correlation with inhibition of PI3K signaling. Free Radic Biol Med 2005, 39:118-132.
12. de la Lastra C.A., Villegas I. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem Soc Trans 2007, 35:1156-1160.
13. Bessler H., Djaldetti M. Role of the equilibrium between colon cancer and mononuclear cells in cytokine production. Biomed Pharmacother 2010, 64:707-711.
14. Bergman M., Djaldetti M., Salman H., Bessler H. Inflammation and colorectal cancer: does aspirin affect the interaction between cancer and immune cells?. Inflammation 2011, 34:22-28.
15. Bergman M., Salman H., Djaldetti M., Bessler H. Statins as modulators of colon cancer cells induced cytokine secretion by human PBMC. Vasc Pharmacol 2011, 54:88-92.
16. Bessler H., Salman H., Bergman M., Djaldetti M. Caffeine alters cytokine secretion by PBMC induced by colon cancer cells. Cancer Investig 2011, 30:87-91.
17. Bessler H., Djaldetti M. Curcumin affects the cross-talk between immunocytes and colon carcinoma cells. Recent Res Devel Nutr 2012, 8:81-93.
18. Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 2007, 81:584-592.
19. Szaffarska A., Baj-Krzyworzeka M., Siedlar M., Weglarczyk K., Ruggiero I., Hajto B., et al. Antitumor response of CD14+/CD16+ monocyte subpopulation. Exp Hematol 2004, 32:748-755.
20. Richard N., Porath D., Radspieler A., Schwager J. Effects of resveratrol, piceatannol, tri-acetoxystilbene, and genistein on the inflammatory response of human peripheral blood leucocytes. Mol Nutr Food Res 2005, 49:431-442.
21. Drutskaya M.S., Efimov G.A., Kruglov A.A., Kuprash D.V., Nedospasov S.A. Tumor necrosis factor, lymphotoxin and cancer. IUBMB Life 2010, 62:283-289.
22. Li T., Fan G.X., Wang W., Li T., Yuan Y.K. Resveratrol induces apoptosis, influences IL-6 and exerts immunomodulatory effect on mouse lymphocytic leukemia both in vitro and in vivo. Int Immunopharmacol 2007, 7:1221-1231.
23. Juan M.E., Alfaras A., Pianas J.M. Colorectal cancer chemoprevention by transreservatrol. Pharmacol Res 2012, 65:584-591.
24. Vanamala J., Reddivari L., Radhaksishnan S., Tarver C. Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways. BMC Cancer 2010, 10:238-251.
25. Shankar S., Singh G., Srivastava R.K. Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential. Front Biosci 2007, 12:4839-4854.
26. Udenigwe C.C., Ramprasath V.R., Aluko R.E., Jones P.J.H. Potential of resveratrol in anticancer and anti-inflammatory therapy. Nutr Rev 2008, 55:445-454.
27. Kaur M., Agarwal C., Agarwal R. Anticancer and cancer chemopreventive potential of grape seed extract and other grape-based products. J Nutr 2009, 139:1806S-1812S.